1rey: Difference between revisions

New page: left|200px<br /><applet load="1rey" size="450" color="white" frame="true" align="right" spinBox="true" caption="1rey, resolution 1.7Å" /> '''HUMAN LYSOZYME-N,N'-D...
 
No edit summary
Line 1: Line 1:
[[Image:1rey.jpg|left|200px]]<br /><applet load="1rey" size="450" color="white" frame="true" align="right" spinBox="true"  
[[Image:1rey.jpg|left|200px]]<br /><applet load="1rey" size="350" color="white" frame="true" align="right" spinBox="true"  
caption="1rey, resolution 1.7&Aring;" />
caption="1rey, resolution 1.7&Aring;" />
'''HUMAN LYSOZYME-N,N'-DIACETYLCHITOBIOSE COMPLEX'''<br />
'''HUMAN LYSOZYME-N,N'-DIACETYLCHITOBIOSE COMPLEX'''<br />


==Overview==
==Overview==
In order to reveal the origin of carbohydrate recognition specificity of, human lysozyme by clarifying the difference in the binding mode of ligands, in the active site, the inactivation of human lysozyme by, 2',3'-epoxypropyl beta-glycoside derivatives of the disaccharides, N,N'-diacetylchitobiose [GlcNAc-beta-(1--&gt;4)-GlcNAc] and, N-acetyllactosamine [Gal-beta-(1--&gt;4)-GlcNAc], was investigated and the, three-dimensional structures of the affinity-labeled enzymes were, determined by X-ray crystallography at 1.7 A resolution. Under the, conditions comprising 2.0 x 10(-3) M labeling reagent and 1.0 x 10(-5) M, human lysozyme at pH 5.4, 37 degrees C, the reaction time required to, reduce the lytic activity against Micrococcus luteus cells to 50% of its, initial activity was lengthened by 3.7 times through the substitution of, the nonreducing end sugar residue, GlcNAc to Gal. The refined structure of, human lysozyme labeled by 2',3'-epoxypropyl beta-glycoside derivatives of, N,N'-diacetylchitobiose (HL/NAG-NAG-EPO complex) indicated that the, interaction mode of the N,N'-diacetylchitobiose moiety in substites B and, C in this study was essentially the same as in the case of the complex of, human lysozyme with the free ligand. On the other hand, the, hydrogen-bonding pattern and the stacking interaction at subsite B were, remarkably different between the HL/NAG-NAG-EPO complex and human lysozyme, labeled by the 2',3'-epoxypropyl beta-glycoside of N-acetyllactosamine, (HL/GAL-NAG-EPO complex). The reduced number of possible hydrogen bonds as, well as the less favorable stacking between the side chain of Tyr63 in, human lysozyme and the galactose residue in the HL/GAL-NAG-EPO complex, reasonably explained the less efficient ability of the 2',3'-epoxypropyl, beta-glycoside of N-acetyllactosamine as compared to that of, N,N'-diacetylchitobiose as an affinity labeling reagent toward human, lysozyme.
In order to reveal the origin of carbohydrate recognition specificity of human lysozyme by clarifying the difference in the binding mode of ligands in the active site, the inactivation of human lysozyme by 2',3'-epoxypropyl beta-glycoside derivatives of the disaccharides, N,N'-diacetylchitobiose [GlcNAc-beta-(1--&gt;4)-GlcNAc] and N-acetyllactosamine [Gal-beta-(1--&gt;4)-GlcNAc], was investigated and the three-dimensional structures of the affinity-labeled enzymes were determined by X-ray crystallography at 1.7 A resolution. Under the conditions comprising 2.0 x 10(-3) M labeling reagent and 1.0 x 10(-5) M human lysozyme at pH 5.4, 37 degrees C, the reaction time required to reduce the lytic activity against Micrococcus luteus cells to 50% of its initial activity was lengthened by 3.7 times through the substitution of the nonreducing end sugar residue, GlcNAc to Gal. The refined structure of human lysozyme labeled by 2',3'-epoxypropyl beta-glycoside derivatives of N,N'-diacetylchitobiose (HL/NAG-NAG-EPO complex) indicated that the interaction mode of the N,N'-diacetylchitobiose moiety in substites B and C in this study was essentially the same as in the case of the complex of human lysozyme with the free ligand. On the other hand, the hydrogen-bonding pattern and the stacking interaction at subsite B were remarkably different between the HL/NAG-NAG-EPO complex and human lysozyme labeled by the 2',3'-epoxypropyl beta-glycoside of N-acetyllactosamine (HL/GAL-NAG-EPO complex). The reduced number of possible hydrogen bonds as well as the less favorable stacking between the side chain of Tyr63 in human lysozyme and the galactose residue in the HL/GAL-NAG-EPO complex reasonably explained the less efficient ability of the 2',3'-epoxypropyl beta-glycoside of N-acetyllactosamine as compared to that of N,N'-diacetylchitobiose as an affinity labeling reagent toward human lysozyme.


==About this Structure==
==About this Structure==
1REY is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with GOL as [http://en.wikipedia.org/wiki/ligand ligand]. Active as [http://en.wikipedia.org/wiki/Lysozyme Lysozyme], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.2.1.17 3.2.1.17] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1REY OCA].  
1REY is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=GOL:'>GOL</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Active as [http://en.wikipedia.org/wiki/Lysozyme Lysozyme], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.2.1.17 3.2.1.17] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1REY OCA].  


==Reference==
==Reference==
Line 23: Line 23:
[[Category: vertebrate c-type]]
[[Category: vertebrate c-type]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Wed Nov 21 01:32:18 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 14:50:09 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA